| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| T-Lymphocytes | 23 | 2024 | 1004 | 3.620 |
Why?
|
| Receptors, Antigen, T-Cell | 26 | 2024 | 279 | 3.100 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 12 | 2020 | 112 | 3.010 |
Why?
|
| Thymus Gland | 10 | 2025 | 239 | 1.830 |
Why?
|
| Histocompatibility Antigens | 8 | 2015 | 107 | 1.800 |
Why?
|
| Peptides | 14 | 2024 | 587 | 1.780 |
Why?
|
| T-Lymphocytes, Regulatory | 7 | 2025 | 219 | 1.450 |
Why?
|
| Major Histocompatibility Complex | 7 | 2024 | 85 | 1.330 |
Why?
|
| Diabetes Mellitus, Type 1 | 3 | 2023 | 630 | 1.200 |
Why?
|
| Complementarity Determining Regions | 4 | 2016 | 33 | 1.190 |
Why?
|
| Autoimmunity | 9 | 2019 | 247 | 1.150 |
Why?
|
| CD4-Positive T-Lymphocytes | 10 | 2023 | 636 | 1.060 |
Why?
|
| CD8-Positive T-Lymphocytes | 7 | 2023 | 673 | 1.010 |
Why?
|
| Autoantigens | 7 | 2024 | 138 | 0.950 |
Why?
|
| T-Lymphocyte Subsets | 6 | 2020 | 241 | 0.880 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 3 | 2020 | 69 | 0.870 |
Why?
|
| Cell Differentiation | 12 | 2025 | 1382 | 0.810 |
Why?
|
| Histocompatibility Antigens Class II | 10 | 2023 | 179 | 0.750 |
Why?
|
| Animals | 48 | 2025 | 21264 | 0.750 |
Why?
|
| Self Tolerance | 3 | 2019 | 20 | 0.740 |
Why?
|
| Mice | 35 | 2025 | 11071 | 0.720 |
Why?
|
| Immune Tolerance | 6 | 2014 | 181 | 0.650 |
Why?
|
| Mice, Inbred C57BL | 18 | 2025 | 3467 | 0.650 |
Why?
|
| Lymphocyte Activation | 10 | 2020 | 752 | 0.620 |
Why?
|
| Myelin Basic Protein | 6 | 2007 | 20 | 0.610 |
Why?
|
| Monocytes | 1 | 2020 | 360 | 0.550 |
Why?
|
| Antigen-Presenting Cells | 5 | 2015 | 178 | 0.520 |
Why?
|
| H-2 Antigens | 4 | 2011 | 63 | 0.520 |
Why?
|
| Dengue | 1 | 2017 | 96 | 0.520 |
Why?
|
| Dengue Virus | 1 | 2017 | 99 | 0.510 |
Why?
|
| Mice, Knockout | 10 | 2025 | 2144 | 0.480 |
Why?
|
| Thymocytes | 3 | 2025 | 23 | 0.470 |
Why?
|
| Adaptive Immunity | 1 | 2015 | 103 | 0.420 |
Why?
|
| Central Nervous System | 3 | 2014 | 200 | 0.420 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2014 | 41 | 0.410 |
Why?
|
| Multiple Sclerosis | 3 | 2014 | 226 | 0.410 |
Why?
|
| Central Nervous System Diseases | 1 | 2014 | 57 | 0.400 |
Why?
|
| Vaccinia | 1 | 2012 | 29 | 0.380 |
Why?
|
| Vaccinia virus | 1 | 2012 | 69 | 0.370 |
Why?
|
| Antigens, Viral | 1 | 2012 | 129 | 0.360 |
Why?
|
| Mice, Transgenic | 11 | 2023 | 1286 | 0.360 |
Why?
|
| Antigens | 3 | 2015 | 145 | 0.290 |
Why?
|
| Ligands | 6 | 2014 | 415 | 0.290 |
Why?
|
| Mice, Inbred NOD | 2 | 2023 | 526 | 0.290 |
Why?
|
| Models, Immunological | 4 | 2015 | 85 | 0.280 |
Why?
|
| Clonal Deletion | 2 | 2025 | 13 | 0.270 |
Why?
|
| T-Lymphocytes, Cytotoxic | 2 | 2017 | 169 | 0.270 |
Why?
|
| Histocompatibility Antigens Class I | 4 | 2014 | 141 | 0.270 |
Why?
|
| Forkhead Transcription Factors | 5 | 2025 | 131 | 0.260 |
Why?
|
| ZAP-70 Protein-Tyrosine Kinase | 2 | 2025 | 7 | 0.260 |
Why?
|
| Spinal Cord | 2 | 2014 | 207 | 0.260 |
Why?
|
| Interleukin-2 | 4 | 2023 | 166 | 0.240 |
Why?
|
| Cross Reactions | 5 | 2012 | 139 | 0.240 |
Why?
|
| Amino Acids | 1 | 2006 | 148 | 0.230 |
Why?
|
| Humans | 25 | 2025 | 64768 | 0.230 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 2 | 2005 | 59 | 0.220 |
Why?
|
| Protein Binding | 6 | 2018 | 1638 | 0.210 |
Why?
|
| Interleukin-17 | 2 | 2020 | 99 | 0.210 |
Why?
|
| Homeodomain Proteins | 2 | 2017 | 277 | 0.200 |
Why?
|
| Antibodies | 1 | 2004 | 187 | 0.200 |
Why?
|
| Immune System | 1 | 2004 | 132 | 0.190 |
Why?
|
| Epitopes, T-Lymphocyte | 3 | 2004 | 184 | 0.190 |
Why?
|
| Peptide Fragments | 6 | 2011 | 415 | 0.180 |
Why?
|
| Cryptosporidium | 1 | 2021 | 4 | 0.180 |
Why?
|
| Cryptosporidiosis | 1 | 2021 | 10 | 0.180 |
Why?
|
| Autoimmune Diseases | 1 | 2024 | 238 | 0.180 |
Why?
|
| Perception | 1 | 2022 | 181 | 0.170 |
Why?
|
| Signal Transduction | 8 | 2024 | 3137 | 0.170 |
Why?
|
| Cell Line | 3 | 2019 | 2019 | 0.170 |
Why?
|
| T-Cell Antigen Receptor Specificity | 3 | 2016 | 10 | 0.160 |
Why?
|
| Epigenomics | 1 | 2020 | 62 | 0.160 |
Why?
|
| Myelin Proteolipid Protein | 1 | 2000 | 7 | 0.160 |
Why?
|
| CD3 Complex | 2 | 2018 | 63 | 0.160 |
Why?
|
| Dermatitis, Atopic | 1 | 2020 | 27 | 0.160 |
Why?
|
| Nervous System | 1 | 2000 | 71 | 0.150 |
Why?
|
| Brain | 2 | 2014 | 1589 | 0.150 |
Why?
|
| Biomarkers | 3 | 2020 | 1469 | 0.150 |
Why?
|
| Immunodominant Epitopes | 1 | 1999 | 57 | 0.150 |
Why?
|
| Insulin | 1 | 2023 | 694 | 0.150 |
Why?
|
| Protein-Arginine Deiminases | 1 | 2019 | 91 | 0.140 |
Why?
|
| Models, Molecular | 4 | 2011 | 1160 | 0.140 |
Why?
|
| Immunomodulation | 1 | 2018 | 29 | 0.140 |
Why?
|
| Adoptive Transfer | 2 | 2012 | 145 | 0.140 |
Why?
|
| Lymph Nodes | 3 | 2016 | 231 | 0.140 |
Why?
|
| Serogroup | 1 | 2017 | 35 | 0.130 |
Why?
|
| Flow Cytometry | 5 | 2014 | 662 | 0.130 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2017 | 74 | 0.130 |
Why?
|
| Transcriptome | 1 | 2020 | 398 | 0.130 |
Why?
|
| Cell Proliferation | 5 | 2016 | 1035 | 0.130 |
Why?
|
| Germ Cells | 1 | 2017 | 118 | 0.120 |
Why?
|
| Wasting Syndrome | 1 | 2016 | 7 | 0.120 |
Why?
|
| Central Tolerance | 1 | 2016 | 2 | 0.120 |
Why?
|
| Cells, Cultured | 4 | 2016 | 2187 | 0.120 |
Why?
|
| Colitis | 1 | 2016 | 77 | 0.110 |
Why?
|
| Aging | 1 | 2001 | 760 | 0.110 |
Why?
|
| Graft vs Host Disease | 1 | 2016 | 113 | 0.110 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2016 | 281 | 0.110 |
Why?
|
| Interferon-gamma | 3 | 2014 | 574 | 0.110 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 309 | 0.110 |
Why?
|
| Protein Conformation | 3 | 2011 | 790 | 0.110 |
Why?
|
| Mice, Inbred Strains | 1 | 2014 | 185 | 0.100 |
Why?
|
| Disease Models, Animal | 4 | 2020 | 2274 | 0.100 |
Why?
|
| Antigen Presentation | 4 | 2008 | 238 | 0.100 |
Why?
|
| Antigens, Neoplasm | 3 | 2002 | 135 | 0.100 |
Why?
|
| Astrocytes | 1 | 2014 | 122 | 0.100 |
Why?
|
| Amino Acid Sequence | 6 | 2008 | 1589 | 0.100 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2012 | 52 | 0.100 |
Why?
|
| Nuclear Proteins | 1 | 2017 | 790 | 0.100 |
Why?
|
| Animals, Newborn | 2 | 2025 | 239 | 0.090 |
Why?
|
| Kinetics | 2 | 2014 | 759 | 0.090 |
Why?
|
| Mutation | 2 | 2018 | 2656 | 0.090 |
Why?
|
| Immunological Synapses | 1 | 2012 | 9 | 0.090 |
Why?
|
| Immunohistochemistry | 1 | 2014 | 895 | 0.090 |
Why?
|
| Bacterial Infections | 1 | 2013 | 150 | 0.090 |
Why?
|
| Time Factors | 4 | 2010 | 3748 | 0.090 |
Why?
|
| Alleles | 2 | 2005 | 449 | 0.090 |
Why?
|
| DNA-Binding Proteins | 1 | 2017 | 1224 | 0.080 |
Why?
|
| Cytokines | 2 | 2012 | 950 | 0.080 |
Why?
|
| Mice, Inbred C3H | 2 | 2001 | 173 | 0.080 |
Why?
|
| Hybridomas | 3 | 2005 | 63 | 0.080 |
Why?
|
| Half-Life | 1 | 2010 | 81 | 0.080 |
Why?
|
| Glycoproteins | 1 | 2011 | 189 | 0.080 |
Why?
|
| Solubility | 1 | 2010 | 191 | 0.080 |
Why?
|
| Baculoviridae | 2 | 2006 | 24 | 0.070 |
Why?
|
| Peptide Library | 2 | 2006 | 33 | 0.070 |
Why?
|
| Male | 4 | 2019 | 30840 | 0.070 |
Why?
|
| Female | 5 | 2019 | 33804 | 0.070 |
Why?
|
| Molecular Sequence Data | 4 | 2006 | 1979 | 0.070 |
Why?
|
| Dendritic Cells | 2 | 2021 | 531 | 0.070 |
Why?
|
| Gene Expression | 3 | 2020 | 849 | 0.070 |
Why?
|
| Interleukin-6 | 2 | 2007 | 322 | 0.070 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2025 | 439 | 0.070 |
Why?
|
| Cytokine Receptor gp130 | 1 | 2007 | 2 | 0.070 |
Why?
|
| Immunologic Memory | 2 | 2023 | 281 | 0.070 |
Why?
|
| Spodoptera | 1 | 2006 | 27 | 0.060 |
Why?
|
| STAT3 Transcription Factor | 1 | 2007 | 70 | 0.060 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2007 | 112 | 0.060 |
Why?
|
| Homeostasis | 2 | 2021 | 376 | 0.060 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2004 | 364 | 0.060 |
Why?
|
| Phospholipase C gamma | 1 | 2025 | 11 | 0.060 |
Why?
|
| Mice, Mutant Strains | 2 | 2008 | 301 | 0.060 |
Why?
|
| Germ-Line Mutation | 1 | 2005 | 47 | 0.060 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2002 | 602 | 0.050 |
Why?
|
| Peripheral Tolerance | 1 | 2024 | 3 | 0.050 |
Why?
|
| Calcium Signaling | 1 | 2025 | 162 | 0.050 |
Why?
|
| Binding Sites | 1 | 2006 | 920 | 0.050 |
Why?
|
| Bone Marrow Cells | 2 | 2001 | 237 | 0.050 |
Why?
|
| Models, Biological | 1 | 2008 | 1192 | 0.050 |
Why?
|
| History, 20th Century | 1 | 2004 | 232 | 0.050 |
Why?
|
| Tuberculosis, Gastrointestinal | 1 | 2002 | 5 | 0.050 |
Why?
|
| Gastrointestinal Agents | 1 | 2002 | 26 | 0.040 |
Why?
|
| Mice, Inbred MRL lpr | 1 | 2001 | 10 | 0.040 |
Why?
|
| Clone Cells | 1 | 2001 | 111 | 0.040 |
Why?
|
| Age Factors | 1 | 2025 | 1568 | 0.040 |
Why?
|
| Lymphoid Tissue | 1 | 2001 | 54 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 2 | 2004 | 875 | 0.040 |
Why?
|
| Gene Dosage | 1 | 2001 | 69 | 0.040 |
Why?
|
| Sexual Maturation | 1 | 2001 | 52 | 0.040 |
Why?
|
| Th1 Cells | 2 | 2014 | 171 | 0.040 |
Why?
|
| Intestines | 1 | 2021 | 178 | 0.040 |
Why?
|
| Crohn Disease | 1 | 2002 | 107 | 0.040 |
Why?
|
| Mice, SCID | 1 | 2001 | 518 | 0.040 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2000 | 72 | 0.040 |
Why?
|
| Spleen | 3 | 2007 | 474 | 0.040 |
Why?
|
| Interleukins | 1 | 2020 | 86 | 0.040 |
Why?
|
| Mice, Inbred A | 1 | 1999 | 20 | 0.040 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 1999 | 27 | 0.040 |
Why?
|
| Keratinocytes | 1 | 2020 | 71 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2025 | 917 | 0.040 |
Why?
|
| Antibodies, Neoplasm | 2 | 1996 | 26 | 0.040 |
Why?
|
| Alternative Splicing | 1 | 2000 | 138 | 0.040 |
Why?
|
| Immunophenotyping | 1 | 2018 | 194 | 0.030 |
Why?
|
| Multiprotein Complexes | 1 | 2018 | 156 | 0.030 |
Why?
|
| Glucocorticoid-Induced TNFR-Related Protein | 1 | 2016 | 6 | 0.030 |
Why?
|
| Clonal Selection, Antigen-Mediated | 1 | 2016 | 5 | 0.030 |
Why?
|
| Tetanus Toxoid | 1 | 1996 | 14 | 0.030 |
Why?
|
| Skin | 1 | 2020 | 416 | 0.030 |
Why?
|
| Antibody Formation | 1 | 1996 | 110 | 0.030 |
Why?
|
| Immunity, Cellular | 1 | 1996 | 170 | 0.030 |
Why?
|
| Insecta | 2 | 2006 | 36 | 0.030 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 1995 | 62 | 0.030 |
Why?
|
| B-Lymphocytes | 2 | 2014 | 563 | 0.030 |
Why?
|
| Vaccines | 1 | 1996 | 96 | 0.030 |
Why?
|
| Adjuvants, Immunologic | 1 | 1996 | 235 | 0.030 |
Why?
|
| Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 1 | 2014 | 8 | 0.030 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2014 | 50 | 0.030 |
Why?
|
| Immunoglobulin A | 1 | 1995 | 102 | 0.030 |
Why?
|
| Markov Chains | 1 | 2014 | 36 | 0.030 |
Why?
|
| Calcium | 2 | 2012 | 581 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 1995 | 285 | 0.030 |
Why?
|
| Colonic Neoplasms | 1 | 1995 | 220 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 1 | 1995 | 343 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2017 | 1410 | 0.020 |
Why?
|
| Infant | 1 | 2017 | 1679 | 0.020 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2004 | 54 | 0.020 |
Why?
|
| B7-1 Antigen | 2 | 2004 | 74 | 0.020 |
Why?
|
| Microscopy, Atomic Force | 1 | 2012 | 31 | 0.020 |
Why?
|
| Lipid Bilayers | 1 | 2012 | 53 | 0.020 |
Why?
|
| Jurkat Cells | 1 | 2012 | 109 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2017 | 2042 | 0.020 |
Why?
|
| Tyrosine | 1 | 2012 | 93 | 0.020 |
Why?
|
| Epitope Mapping | 1 | 2011 | 52 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2012 | 261 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2011 | 251 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 2012 | 224 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2011 | 419 | 0.020 |
Why?
|
| Lipids | 1 | 2012 | 327 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2010 | 354 | 0.020 |
Why?
|
| Ovalbumin | 2 | 2000 | 108 | 0.020 |
Why?
|
| Surface Plasmon Resonance | 1 | 2008 | 32 | 0.020 |
Why?
|
| Protein Structure, Quaternary | 1 | 2008 | 102 | 0.020 |
Why?
|
| Child | 1 | 2017 | 4554 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 2008 | 173 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2010 | 504 | 0.020 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2007 | 16 | 0.020 |
Why?
|
| Mice, Inbred DBA | 1 | 2007 | 84 | 0.020 |
Why?
|
| Arthritis, Experimental | 1 | 2007 | 30 | 0.020 |
Why?
|
| Receptors, Thyroid Hormone | 1 | 2007 | 27 | 0.020 |
Why?
|
| Lymphocyte Transfusion | 1 | 2007 | 37 | 0.020 |
Why?
|
| Cell Count | 1 | 2007 | 128 | 0.020 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2007 | 55 | 0.020 |
Why?
|
| Computational Biology | 1 | 2008 | 366 | 0.020 |
Why?
|
| Enterotoxins | 1 | 2006 | 20 | 0.020 |
Why?
|
| Proteins | 1 | 2012 | 764 | 0.020 |
Why?
|
| Gene Library | 1 | 2004 | 102 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2008 | 1564 | 0.010 |
Why?
|
| DNA, Viral | 1 | 2004 | 229 | 0.010 |
Why?
|
| Epitopes | 1 | 2004 | 291 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2004 | 414 | 0.010 |
Why?
|
| Cell Extracts | 1 | 2002 | 26 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2002 | 58 | 0.010 |
Why?
|
| Oligonucleotides | 1 | 2004 | 229 | 0.010 |
Why?
|
| fas Receptor | 1 | 2002 | 56 | 0.010 |
Why?
|
| ras Proteins | 1 | 2002 | 76 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2002 | 104 | 0.010 |
Why?
|
| Enteritis | 1 | 2002 | 13 | 0.010 |
Why?
|
| Infliximab | 1 | 2002 | 50 | 0.010 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2002 | 140 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2002 | 212 | 0.010 |
Why?
|
| Cell Division | 1 | 2002 | 449 | 0.010 |
Why?
|
| Culture Media, Serum-Free | 1 | 2000 | 10 | 0.010 |
Why?
|
| Hemocyanins | 1 | 2000 | 24 | 0.010 |
Why?
|
| CD40 Antigens | 1 | 2000 | 59 | 0.010 |
Why?
|
| Coculture Techniques | 1 | 2000 | 104 | 0.010 |
Why?
|
| Mice, Neurologic Mutants | 1 | 1999 | 13 | 0.010 |
Why?
|
| Cell Communication | 1 | 2000 | 133 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2002 | 987 | 0.010 |
Why?
|
| Oligopeptides | 1 | 1999 | 134 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 1999 | 237 | 0.010 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2002 | 417 | 0.010 |
Why?
|
| Radiation Chimera | 1 | 1997 | 61 | 0.010 |
Why?
|
| Alum Compounds | 1 | 1996 | 3 | 0.010 |
Why?
|
| Hypersensitivity, Delayed | 1 | 1996 | 19 | 0.010 |
Why?
|
| Injections, Intradermal | 1 | 1996 | 12 | 0.010 |
Why?
|
| Freund's Adjuvant | 1 | 1996 | 14 | 0.010 |
Why?
|
| Hematopoiesis | 1 | 1997 | 127 | 0.010 |
Why?
|
| Rats, Inbred F344 | 1 | 1996 | 56 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 1997 | 218 | 0.010 |
Why?
|
| Injections, Subcutaneous | 1 | 1996 | 70 | 0.010 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1995 | 13 | 0.010 |
Why?
|
| Oncogene Protein p21(ras) | 1 | 1995 | 4 | 0.010 |
Why?
|
| Antibodies, Bacterial | 1 | 1996 | 181 | 0.010 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 1995 | 35 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1996 | 449 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 1996 | 463 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 1997 | 410 | 0.010 |
Why?
|
| Rats | 1 | 1996 | 1990 | 0.010 |
Why?
|
| Middle Aged | 1 | 2002 | 18156 | 0.000 |
Why?
|